Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4208583 | Journal of Cystic Fibrosis | 2011 | 8 Pages |
BackgroundThe clinical consequences of chronic Stenotrophomonas maltophilia infection in cystic fibrosis (CF) patient are still unclear.MethodAll patients treated in the Copenhagen CF centre (N = 278) from 1 January 2008 to 31 December 2009 were included. Each patient chronically infected with S. maltophilia for at least 2 years without any other chronic Gram-negative infection were matched to two non-infected CF controls.ResultsTwenty-one patients were chronically infected with S. maltophilia during the 2-year study period. Fifteen were infected for at least 2 years.The patients in the S. maltophilia group had a steeper decline (− 3.2%/year vs. −0.3%/year) in FEV1 compared to the non-infected CF controls (P = 0.03). The rate of decline was the same as observed 3 years before the patients became chronically infected.DiscussionsChronic infection with S. maltophilia does not lead to a steeper decline in lung function when compared to the period before chronic infection.